HEPATITIS C GENOTYPING

Code
900.1750
Name
HEPATITIS C GENOTYPING
Category
None
Department
Send-Out
Start Date
Expiration Date
Synonyms
HCV Genotyping by RT-PCR
CPT Codes
87902
Site
SBMF
Reference Test
36123
ATLAS Test Code

Specimen Information

Type

Two (2) Pearl white top (PPT; EDTA + gel barrier) tubes

Volume

3.0 ml

Transport Info

Refrigerated
Separate samples must be submitted when multiple tests are ordered

Fasting Required?
False
Patient Instructions

Reference Range

See Report

Methodology

Reverse Transcription and Real-Time Polymerase Chain Reaction (RT-PCR)

Clinical Significance

Aid in the clinical management and prognosis of HCV infection.

HCV infection is a leading cause of chronic hepatitis, cirrhosis and hepatocellular carcinoma, with more than 170 million people chronically infected worldwide. Very effective treatment is now available. The combination of pegylated interferon and ribavirin can eradicate the virus in more than 50% of patients. These antiviral treatments reduce liver fibrosis progression and can reverse cirrhosis. Knowledge of the genotype and viral load results help to predict sustained virological response and the choice of treatment duration. Response rates to treatment by pegylated interferon and ribavirin combination are about 88% for genotypes 2 and 3 and 48% for the other 4 genotypes. Genotypes do not change during the course of infection; however, co-infections are known to exist.

Back

Patients & Visitors

Make a First Appointment Maternity Pre-Registration Make a Donation Recognize a Sarah Bush Lincoln Employee